Literature DB >> 31070373

Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB.

Alessio Atzori1, Giuliano Malloci1, Jigneshkumar Dahyabhai Prajapati2, Andrea Basciu1, Andrea Bosin1, Ulrich Kleinekathöfer2, Jürg Dreier3, Attilio V Vargiu1, Paolo Ruggerone1.   

Abstract

The drug/proton antiporter AcrB, part of the major efflux pump AcrABZ-TolC in Escherichia coli, is characterized by its impressive ability to transport chemically diverse compounds, conferring a multidrug resistance phenotype. However, the molecular features differentiating between good and poor substrates of the pump have yet to be identified. In this work, we combined molecular docking with molecular dynamics simulations to study the interactions between AcrB and two representative cephalosporins, cefepime and ceftazidime (a good and poor substrate of AcrB, respectively). Our analysis revealed different binding preferences of the two compounds toward the subsites of the large deep binding pocket of AcrB. Cefepime, although less hydrophobic than ceftazidime, showed a higher affinity than ceftazidime for the so-called hydrophobic trap, a region known for binding inhibitors and substrates. This supports the hypothesis that surface complementarity between the molecule and AcrB, more than the intrinsic hydrophobicity of the antibiotic, is a feature required for the interaction within this region. Oppositely, the preference of ceftazidime for binding outside the hydrophobic trap might not be optimal for triggering allosteric conformational changes needed to the transporter to accomplish its function. Altogether, our findings could provide valuable information for the design of new antibiotics less susceptible to the efflux mechanism.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31070373      PMCID: PMC6939625          DOI: 10.1021/acs.jpcb.9b01351

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  72 in total

1.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

Authors:  P A Kollman; I Massova; C Reyes; B Kuhn; S Huo; L Chong; M Lee; T Lee; Y Duan; W Wang; O Donini; P Cieplak; J Srinivasan; D A Case; T E Cheatham
Journal:  Acc Chem Res       Date:  2000-12       Impact factor: 22.384

2.  Crystallographic analysis of AcrB.

Authors:  Klaas M Pos; André Schiefner; Markus A Seeger; Kay Diederichs
Journal:  FEBS Lett       Date:  2004-04-30       Impact factor: 4.124

Review 3.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 4.  Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

Review 5.  RND efflux pumps: structural information translated into function and inhibition mechanisms.

Authors:  Paolo Ruggerone; Satoshi Murakami; Klaas M Pos; Attilio V Vargiu
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

6.  Effect of the F610A mutation on substrate extrusion in the AcrB transporter: explanation and rationale by molecular dynamics simulations.

Authors:  Attilio V Vargiu; Francesca Collu; Robert Schulz; Klaas M Pos; Martin Zacharias; Ulrich Kleinekathöfer; Paolo Ruggerone
Journal:  J Am Chem Soc       Date:  2011-06-27       Impact factor: 15.419

7.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.

Authors:  James A Maier; Carmenza Martinez; Koushik Kasavajhala; Lauren Wickstrom; Kevin E Hauser; Carlos Simmerling
Journal:  J Chem Theory Comput       Date:  2015-07-23       Impact factor: 6.006

8.  Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.

Authors:  Attilio V Vargiu; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

Review 9.  Multidrug efflux pumps: structure, function and regulation.

Authors:  Dijun Du; Xuan Wang-Kan; Arthur Neuberger; Hendrik W van Veen; Klaas M Pos; Laura J V Piddock; Ben F Luisi
Journal:  Nat Rev Microbiol       Date:  2018-09       Impact factor: 60.633

10.  An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump.

Authors:  Zhao Wang; Guizhen Fan; Corey F Hryc; James N Blaza; Irina I Serysheva; Michael F Schmid; Wah Chiu; Ben F Luisi; Dijun Du
Journal:  Elife       Date:  2017-03-29       Impact factor: 8.140

View more
  8 in total

1.  Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides.

Authors:  Napoleon D'Cunha; Mohammad Moniruzzaman; Keith Haynes; Giuliano Malloci; Connor J Cooper; Enrico Margiotta; Attilio V Vargiu; Muhammad R Uddin; Inga V Leus; Feng Cao; Jerry M Parks; Valentin V Rybenkov; Paolo Ruggerone; Helen I Zgurskaya; John K Walker
Journal:  ACS Infect Dis       Date:  2021-08-11       Impact factor: 5.578

2.  Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa.

Authors:  Silvia Gervasoni; Giuliano Malloci; Andrea Bosin; Attilio V Vargiu; Helen I Zgurskaya; Paolo Ruggerone
Journal:  Phys Chem Chem Phys       Date:  2022-07-13       Impact factor: 3.945

3.  Biosynthetic Incorporation of Site-Specific Isotopes in β-Lactam Antibiotics Enables Biophysical Studies.

Authors:  Jacek Kozuch; Samuel H Schneider; Steven G Boxer
Journal:  ACS Chem Biol       Date:  2020-03-20       Impact factor: 5.100

4.  The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux.

Authors:  Julia Vergalli; Alessio Atzori; Jean-Marie Pagès; Jelena Pajovic; Estelle Dumont; Giuliano Malloci; Muriel Masi; Attilio Vittorio Vargiu; Mathias Winterhalter; Matthieu Réfrégiers; Paolo Ruggerone
Journal:  Commun Biol       Date:  2020-04-28

5.  Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli.

Authors:  Alessio Atzori; Giuliano Malloci; Francesca Cardamone; Andrea Bosin; Attilio Vittorio Vargiu; Paolo Ruggerone
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

6.  Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.

Authors:  Coline Plé; Heng-Keat Tam; Anais Vieira Da Cruz; Nina Compagne; Juan-Carlos Jiménez-Castellanos; Reinke T Müller; Elizabeth Pradel; Wuen Ee Foong; Giuliano Malloci; Alexia Ballée; Moritz A Kirchner; Parisa Moshfegh; Adrien Herledan; Andrea Herrmann; Benoit Deprez; Nicolas Willand; Attilio Vittorio Vargiu; Klaas M Pos; Marion Flipo; Ruben C Hartkoorn
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

7.  A framework for dissecting affinities of multidrug efflux transporter AcrB to fluoroquinolones.

Authors:  Julia Vergalli; Hugo Chauvet; Francesco Oliva; Jelena Pajović; Giuliano Malloci; Attilio Vittorio Vargiu; Matthieu Réfrégiers; Paolo Ruggerone; Jean-Marie Pagès
Journal:  Commun Biol       Date:  2022-10-06

8.  Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.

Authors:  Elizabeth M Grimsey; Chiara Fais; Robert L Marshall; Vito Ricci; Maria Laura Ciusa; Jack W Stone; Alasdair Ivens; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.